This was significantly younger than the other 450 patients with conventional IDH-wildtype glioblastomas lacking somatic hypermutation and mismatch repair deficiency who had a median age at diagnosis of 63 years (p < 0.01). This evidence concerns the gene IDH2 and glioblastoma.